Your browser doesn't support javascript.
loading
Contrast-enhanced CT and liver surface nodularity for the diagnosis of porto-sinusoidal vascular disorder: A case-control study.
Valainathan, Shantha Ram; Sartoris, Riccardo; Elkrief, Laure; Magaz, Marta; Betancourt, Fabian; Pellegrino, Silvia; Nivolli, Arianna; Dioguardi Burgio, Marco; Flattet, Yves; Terraz, Sylvain; Drilhon, Nicolas; Lazareth, Marie; Herrou, Julia; Bruno, Onorina; Payance, Audrey; Plessier, Aurélie; Durand, François; Ronot, Maxime; Valla, Dominique-Charles; Paradis, Valérie; Garcia-Pagan, Juan Carlos; Vilgrain, Valérie; Rautou, Pierre-Emmanuel.
Afiliação
  • Valainathan SR; Service d'Hépatologie, DMU DIGEST, Centre de Référence des Maladies Vasculaires du Foie, FILFOIE, ERN RARE-LIVER, Centre de Recherche sur l'inflammation, Inserm, UMR 1149, Université de Paris, AP-HP, Hôpital Beaujon, Paris, France.
  • Sartoris R; Centre de Recherche sur l'inflammation, Inserm, UMR 1149, Université de Paris, Paris, France.
  • Elkrief L; Department of Radiology, AP-HP Nord, Hôpital Beaujon, Clichy, France.
  • Magaz M; Service d'Hépato-gastroentérologie, Hôpitaux Universitaires de Genève, Geneva, Switzerland.
  • Betancourt F; Service d'Hépato-Gastroentérologie, Hôpital Trousseau, CHRU de Tours, Tours, France.
  • Pellegrino S; Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Clínic de Barcelona, IDIBAPS, CIBERehd, European Reference Network for Rare Vascular Liver Diseases, Universitat de Barcelona, Barcelona, Spain.
  • Nivolli A; Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Clínic de Barcelona, IDIBAPS, CIBERehd, European Reference Network for Rare Vascular Liver Diseases, Universitat de Barcelona, Barcelona, Spain.
  • Dioguardi Burgio M; Centre de Recherche sur l'inflammation, Inserm, UMR 1149, Université de Paris, Paris, France.
  • Flattet Y; Department of Radiology, AP-HP Nord, Hôpital Beaujon, Clichy, France.
  • Terraz S; Centre de Recherche sur l'inflammation, Inserm, UMR 1149, Université de Paris, Paris, France.
  • Drilhon N; Department of Radiology, AP-HP Nord, Hôpital Beaujon, Clichy, France.
  • Lazareth M; Centre de Recherche sur l'inflammation, Inserm, UMR 1149, Université de Paris, Paris, France.
  • Herrou J; Department of Radiology, AP-HP Nord, Hôpital Beaujon, Clichy, France.
  • Bruno O; Service d'Hépato-gastroentérologie, Hôpitaux Universitaires de Genève, Geneva, Switzerland.
  • Payance A; Department of Radiology, University Hospitals of Geneva, Geneva, Switzerland.
  • Plessier A; Service d'Hépatologie, DMU DIGEST, Centre de Référence des Maladies Vasculaires du Foie, FILFOIE, ERN RARE-LIVER, Centre de Recherche sur l'inflammation, Inserm, UMR 1149, Université de Paris, AP-HP, Hôpital Beaujon, Paris, France.
  • Durand F; Service d'Hépatologie, DMU DIGEST, Centre de Référence des Maladies Vasculaires du Foie, FILFOIE, ERN RARE-LIVER, Centre de Recherche sur l'inflammation, Inserm, UMR 1149, Université de Paris, AP-HP, Hôpital Beaujon, Paris, France.
  • Ronot M; Department of Rhumatology, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Valla DC; Centre de Recherche sur l'inflammation, Inserm, UMR 1149, Université de Paris, Paris, France.
  • Paradis V; Department of Radiology, AP-HP Nord, Hôpital Beaujon, Clichy, France.
  • Garcia-Pagan JC; Service d'Hépatologie, DMU DIGEST, Centre de Référence des Maladies Vasculaires du Foie, FILFOIE, ERN RARE-LIVER, Centre de Recherche sur l'inflammation, Inserm, UMR 1149, Université de Paris, AP-HP, Hôpital Beaujon, Paris, France.
  • Vilgrain V; Service d'Hépatologie, DMU DIGEST, Centre de Référence des Maladies Vasculaires du Foie, FILFOIE, ERN RARE-LIVER, Centre de Recherche sur l'inflammation, Inserm, UMR 1149, Université de Paris, AP-HP, Hôpital Beaujon, Paris, France.
  • Rautou PE; Service d'Hépatologie, DMU DIGEST, Centre de Référence des Maladies Vasculaires du Foie, FILFOIE, ERN RARE-LIVER, Centre de Recherche sur l'inflammation, Inserm, UMR 1149, Université de Paris, AP-HP, Hôpital Beaujon, Paris, France.
Hepatology ; 76(2): 418-428, 2022 08.
Article em En | MEDLINE | ID: mdl-35092315
ABSTRACT
BACKGROUND AND

AIMS:

Porto-sinusoidal vascular disorder (PSVD) is a rare and commonly overlooked cause of portal hypertension. The interest of CT analysis, including quantification of liver surface nodularity (LSN) for PSVD diagnosis has not been established. This study aimed at assessing the performance of LSN and CT features for a PSVD diagnosis in patients with signs of portal hypertension. APPROACH AND

RESULTS:

This retrospective case-control study included a learning cohort consisting of 50 patients with histologically proven PSVD, according to VALDIG criteria, and 100 control patients with histologically proven cirrhosis, matched on ascites. All patients and controls had at least one sign of portal hypertension and CT available within 1 year of liver biopsy. Principal component analysis of CT features separated patients with PSVD from patients with cirrhosis. Patients with PSVD had lower median LSN than those with cirrhosis (2.4 vs. 3.1, p < 0.001). Multivariate analysis identified LSN < 2.5 and normal-sized or enlarged segment IV as independently associated with PSVD. Combination of these two features had a specificity of 90% for PSVD and a diagnostic accuracy of 84%. Even better results were obtained in an independent multicenter validation cohort including 53 patients with PSVD and 106 control patients with cirrhosis (specificity 94%, diagnostic accuracy 87%).

CONCLUSIONS:

This study that included a total of 103 patients with PSVD and 206 patients with cirrhosis demonstrates that LSN < 2.5 combined with normal-sized or enlarged segment IV strongly suggests PSVD in patients with signs of portal hypertension.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Vasculares / Hipertensão Portal Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Vasculares / Hipertensão Portal Idioma: En Ano de publicação: 2022 Tipo de documento: Article